American Journal of Cardiology
Volume 99, Issue 2 , Pages 154-158 , 15 January 2007

Blood Omega-3 and Trans Fatty Acids in Middle-Aged Acute Coronary Syndrome Patients

  • William S. Harris, PhD

      Affiliations

    • Sanford Research and School of Medicine, University of South Dakota, Sioux Falls, South Dakota.
    • Corresponding Author InformationCorresponding author: Tel: 605-357-1522; fax: 605-357-1409.
  • ,
  • Kimberly J. Reid, MS

      Affiliations

    • Division of Cardiovascular Research, Saint Luke’s Mid America Heart Institute, Kansas City, Missouri
  • ,
  • Scott A. Sands, PhD

      Affiliations

    • Division of Cardiovascular Research, Saint Luke’s Mid America Heart Institute, Kansas City, Missouri
  • ,
  • John A. Spertus, MD, MPH

      Affiliations

    • Division of Cardiovascular Research, Saint Luke’s Mid America Heart Institute, Kansas City, Missouri
    • Department of Medicine, University of Missouri–Kansas City, Kansas City, Missouri

Received 31 May 2006 ,Revised 7 August 2006 ,Accepted 7 August 2006.

References 

  1. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747–2757
  2. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med. 1995;332:977–982
  3. Morris MC, Manson JE, Rosner B, Buring JE, Willett WC, Hennekens CH. Fish consumption and cardiovascular disease in the Physicians’ Health Study: a prospective study. Am J Epidemiol. 1995;142:166–175
  4. Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA. 2002;287:1815–1821
  5. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2:757–761
  6. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, et al Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002;105:1897–1903
  7. Pedersen JI, Ringstad J, Almendingen K, Haugen TS, Stensvold I, Thelle DS. Adipose tissue fatty acids and risk of myocardial infarction—a case-control study. Eur J Clin Nutr. 2000;54:618–625
  8. Kirkeby K, Ingualdsen P, Bjerkedal I. Fatty acid composition of serum lipids in men with myocardial infarction. Acta Med Scand. 1972;192:513–519
  9. Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med. 1997;337:1491–1499
  10. Oomen CM, Ocke MC, Feskens EJ, van Erp-Baart MA, Kok FJ, Kromhout D. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet. 2001;357:746–751
  11. Bolton-Smith C, Woodward M, Fenton S, Brown CA. Does dietary trans fatty acid intake relate to the prevalence of coronary heart disease in Scotland?. Eur Heart J. 1996;17:837–845
  12. Lemaitre RN, King IB, Raghunathan TE, Pearce RM, Weinmann S, Knopp RH, et al. Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation. 2002;105:697–701
  13. Aro A, Kardinaal AF, Salminen I, Kark JD, Riemersma RA, Delgado-Rodriguez M, et al. Adipose tissue isomeric trans fatty acids and risk of myocardial infarction in nine countries: the EURAMIC study. Lancet. 1995;345:273–278
  14. Roberts TL, Wood DA, Riemersma RA, Gallagher PJ, Lampe FC. Trans isomers of oleic and linoleic acids in adipose tissue and sudden cardiac death. Lancet. 1995;345:278–282
  15. Lanfear DE, Jones PG, Marsh S, Cresci S, McLeod HL, Spertus JA. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome. JAMA. 2005;294:1526–1533
  16. Harris WS, von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease?. Prev Med. 2004;39:212–220
  17. Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, et al. N-3 fatty acids from fish or fish-oil supplements, but not {alpha}-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr. 2006;84:5–17
  18. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113–1118
  19. Rissanen T, Voutilainen S, Nyyssönen K, Lakka TA, Salonen JT. Fish oil–derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events (The Kuopio Ischaemic Heart Disease Risk Factor Study). Circulation. 2000;102:2677–2679
  20. Erkkila AT, Lehto S, Pyorala K, Uusitupa MI. N-3 fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease. Am J Clin Nutr. 2003;78:65–71
  21. Hallgren CG, Hallmans G, Jansson JH, Marklund SL, Huhtasaari F, Schutz A, et al. Markers of high fish intake are associated with decreased risk of a first myocardial infarction. Br J Nutr. 2001;86:397–404
  22. Guallar E, Aro A, Jimenez FJ, Martin-Moreno JM, Salminen I, van’t Veer P, et al Omega-3 fatty acids in adipose tissue and risk of myocardial infarction (The EURAMIC Study). Arterioscl Thromb Vasc Biol. 1999;19:1111–1118
  23. Durak I, Elgun S, Kemal BN, Burak Cimen MY, Kacmaz M, Buyukkocak S, et al. Effects of cigarette smoking with different tar content on erythrocyte oxidant/antioxidant status. Addict Biol. 2002;7:255–258
  24. Kark JD, Manor O, Goldman S, Berry EM. Stability of red blood cell membrane fatty acid composition after acute myocardial infarction. J Clin Epidemiol. 1995;48:889–895
  25. Maidment CG, Jones SP, Lea EJ. Changes in platelet membrane fatty acids after myocardial infarction. Atherosclerosis. 1988;74:9–14

 This project was funded by grants from the Saint Luke’s Hospital Foundation, Kansas City, Missouri, and by Grant R-01 HS11282-01 from the Agency for Healthcare Research and Quality, Rockville, Maryland.

PII: S0002-9149(06)01994-1

doi: 10.1016/j.amjcard.2006.08.013

American Journal of Cardiology
Volume 99, Issue 2 , Pages 154-158 , 15 January 2007